CSIMarket
 

Melinta Therapeutics, Inc.  (CEMP)
Other Ticker:  
 

Melinta Therapeutics,'s Working Capital Per Sales

CEMP's Working Capital and Revenue growth



CEMP Working Capital Per Revenue (Sep 30 2019)
III. Quarter
(Jun 30 2019)
II. Quarter
(Mar 31 2019)
I. Quarter
(Dec 31 2018)
IV. Quarter
(Sep 30 2018)
III. Quarter
Y / Y Working Capital Change -92.22 % -76.4 % -52.05 % -86.55 % -74.77 %
Y / Y Revenue Change -53.43 % 32.72 % -5.1 % - 1884.74 %
Working Capital Per Revenue 0.29 0.33 0.55 0.7 1.52
Total Ranking # 2460 # 2458 # 2460 # 2461 # 0
Seq. Working Capital Change -86.79 % -52.94 % 226.25 % -61.66 % -59.9 %
Seq. Revenue Change -0.53 % 13.28 % -60.31 % 4.14 % 183.46 %





Comment on CEMP's Working Capital Per Revenue in the third quarter 2019
Melinta Therapeutics,'s Working Capital Per Revenue in the Q3 2019 sequentially fell to 0.29 a new company low. Due to decrease of revenue year on year in the third quarter 2019 by -53.43%.

Within Healthcare sector 90 other companies have achieved lower Working Capital Per Revenue during the Q3 2019. While Working Capital Per Revenue total ranking has deteriorated in the third quarter 2019, compared to previous quarter from 2458 to 2460.
Working Capital Per Revenue Ranking
Within: No.
Industry # 32
Sector # 91
S&P 500 # 2460


Working Capital Per Revenue Statistics
High Average Low
13.03
7.67
0.29
(June 30. 2016)   (Sep 30 2019)



Financial Statements
Melinta Therapeutics,'s Working Capital $ 3 Millions Visit CEMP's Balance sheet
Melinta Therapeutics,'s Revenues $ 16 Millions Visit CEMP's Income Statement
Where are CEMP's Sales coming from? Visit CEMP's Sales by Geography




Companies with similar Average Working Capital Per Revenue for 12 months ending Sep 30 2019, within Healthcare Sector Working Capital Per Revenue
Intuitive Surgical Inc   0.79 
Atrion Corporation  0.77 
Incyte Corporation  0.77 
Catalyst Pharmaceuticals Inc   0.76 
Innovation1 Biotech Inc   0.76 
Pacific Biosciences Of California Inc   0.75 
Fonar Corporation  0.75 
Bristol myers Squibb Company  0.75 
Amag Pharmaceuticals inc   0.74 
Enzo Biochem Inc  0.74 
Inogen Inc   0.73 
Glaukos Corp  0.73 
Luna Innovations Inc  0.73 
Cytosorbents Corporation  0.72 
Corcept Therapeutics Inc  0.72 
Seagen Inc   0.72 
Jounce Therapeutics inc   0.70 
Bio rad Laboratories Inc   0.70 
Supernus Pharmaceuticals inc   0.69 
Globus Medical Inc   0.69 
Penumbra Inc   0.68 
Abiomed Inc   0.68 
Lemaitre Vascular Inc   0.67 
Regeneron Pharmaceuticals Inc   0.67 
Aveo Pharmaceuticals Inc   0.66 
Eagle Pharmaceuticals inc   0.65 
Electromed Inc   0.64 
Pro dex Inc   0.64 
Standard Biotools Inc   0.64 
Dariohealth Corp   0.64 
Date modified: -0001-11-30T00:00:00+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com